RET and thyroiditis: In thyroid cancer cell lines with RET/PTC or BRAF oncogenic mutations cyclinD1-CDK4 complex is more abundant than cyclinD3-CDK4, suggesting the dominant character of cyclin D1 complexes formation in thyroid oncogenesis [30].